D Pavan-Langston, C H Dohlman. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adenine/adverse effectsAdenine/therapeutic useAdenoviridae Infections/drug therapyAntiviral AgentsArabinose/adverse effectsArabinose/therapeutic useClinical Trials as TopicDrug HypersensitivityEvaluation Studies as TopicHumansIdoxuridine/adverse effectsIdoxuridine/therapeutic useKeratitis, Dendritic/drug therapyKeratoconjunctivitis/drug therapyNucleosides/adverse effectsNucleosides/therapeutic useTime FactorsUveitis/drug therapyVaccinia/drug therapyVirus Diseases/drug therapy
Substances: See more » Antiviral AgentsNucleosidesArabinoseAdenineIdoxuridine
Year: 1972 PMID: 4338612 DOI: 10.1016/0002-9394(72)91130-0
Source DB: PubMed Journal: Am J Ophthalmol ISSN: 0002-9394 Impact factor: 5.258